On March 25, 2025, Canada’s Drug Agency published its annual Watch List, which identifies technologies with the most potential to transform health systems and shape the future of health care in Canada. The 2025 Watch List highlights the top AI technologies and related issues poised to impact health care systems in Canada.
Top five AI technologies:
- AI for notetaking
- AI in clinical training
- AI for disease diagnosis
- AI for disease treatment
- AI for remote monitoring
Top five issues:
- Privacy & data security
- Liability & accountability
- Data availability, quality & bias
- Data sovereignty & governance
- Environmental costs
Should you have any questions, please do not hesitate to contact a member of the Life Sciences Regulatory & Compliance Group.
Related Publications & Articles
-
Health Canada finalizes biosimilar guidance: comparative clinical efficacy studies not typically required
In Canada, biosimilar products are approved by way of a new drug submission, following Health Canada guidance first released in 2010 and significantly revised in 2016.Read More -
2026 mid-year highlights in Canadian life sciences IP and regulatory law
In the first half of 2026, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top storiesRead More -
Supreme Court of Canada: methods of medical treatment unpatentable, validity of Janssen’s paliperidone dosing regimen patent upheld
Today the Supreme Court of Canada released its decision in Pharmascience Inc v Janssen Inc, 2026 SCC 26 on the patentability of methods of medical treatment, dismissing Pharmascience’s appeal.Read More
